TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs
- PMID: 39454312
- PMCID: PMC12228977
- DOI: 10.1016/j.media.2024.103373
TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs
Abstract
Characterization of breast parenchyma in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a challenging task owing to the complexity of underlying tissue structures. Existing quantitative approaches, like radiomics and deep learning models, lack explicit quantification of intricate and subtle parenchymal structures, including fibroglandular tissue. To address this, we propose a novel topological approach that explicitly extracts multi-scale topological structures to better approximate breast parenchymal structures, and then incorporates these structures into a deep-learning-based prediction model via an attention mechanism. Our topology-informed deep learning model, TopoTxR, leverages topology to provide enhanced insights into tissues critical for disease pathophysiology and treatment response. We empirically validate TopoTxR using the VICTRE phantom breast dataset, showing that the topological structures extracted by our model effectively approximate the breast parenchymal structures. We further demonstrate TopoTxR's efficacy in predicting response to neoadjuvant chemotherapy. Our qualitative and quantitative analyses suggest differential topological behavior of breast tissue in treatment-naïve imaging, in patients who respond favorably to therapy as achieving pathological complete response (pCR) versus those who do not. In a comparative analysis with several baselines on the publicly available I-SPY 1 dataset (N = 161, including 47 patients with pCR and 114 without) and the Rutgers proprietary dataset (N = 120, with 69 patients achieving pCR and 51 not), TopoTxR demonstrates a notable improvement, achieving a 2.6% increase in accuracy and a 4.6% enhancement in AUC compared to the state-of-the-art method.
Keywords: 3D CNN; DCE-MRI; Persistent homology; Spatial attention; Topology; pCR prediction.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest All authors disclosed no relevant relationships.
Figures








Similar articles
-
A two-stage dual-task learning strategy for early prediction of pathological complete response to neoadjuvant chemotherapy for breast cancer using dynamic contrast-enhanced magnetic resonance images.Phys Med Biol. 2025 Jul 18;70(14):145030. doi: 10.1088/1361-6560/adee73. Phys Med Biol. 2025. PMID: 40639409 Free PMC article.
-
Refined prognostication of pathological complete response in breast cancer using radiomic features and optimized InceptionV3 with DCE-MRI.Sci Rep. 2025 Jul 30;15(1):27844. doi: 10.1038/s41598-025-08565-3. Sci Rep. 2025. PMID: 40739101 Free PMC article.
-
Synthesizing late-stage contrast enhancement in breast MRI: A comprehensive pipeline leveraging temporal contrast enhancement dynamics.Comput Biol Med. 2025 Sep;196(Pt A):110660. doi: 10.1016/j.compbiomed.2025.110660. Epub 2025 Jul 12. Comput Biol Med. 2025. PMID: 40652758
-
MRI-Based Radiomics Methods for Predicting Ki-67 Expression in Breast Cancer: A Systematic Review and Meta-analysis.Acad Radiol. 2024 Mar;31(3):763-787. doi: 10.1016/j.acra.2023.10.010. Epub 2023 Nov 2. Acad Radiol. 2024. PMID: 37925343
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
Cited by
-
Deep learning-driven multi-omics analysis: enhancing cancer diagnostics and therapeutics.Brief Bioinform. 2025 Jul 2;26(4):bbaf440. doi: 10.1093/bib/bbaf440. Brief Bioinform. 2025. PMID: 40874818 Free PMC article. Review.
-
Spatial-temporal radiogenomics in predicting neoadjuvant chemotherapy efficacy for breast cancer: a comprehensive review.J Transl Med. 2025 Jun 18;23(1):681. doi: 10.1186/s12967-025-06641-w. J Transl Med. 2025. PMID: 40533825 Free PMC article. Review.
-
TopoCellGen: Generating Histopathology Cell Topology with a Diffusion Model.Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit. 2025 Jun;2025:20979-20989. doi: 10.1109/cvpr52734.2025.01954. Epub 2025 Aug 13. Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit. 2025. PMID: 40873442 Free PMC article.
-
Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer.Adv Sci (Weinh). 2025 Mar;12(12):e2413702. doi: 10.1002/advs.202413702. Epub 2025 Feb 7. Adv Sci (Weinh). 2025. PMID: 39921294 Free PMC article.
-
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.Biol Direct. 2025 Jun 23;20(1):72. doi: 10.1186/s13062-025-00661-8. Biol Direct. 2025. PMID: 40551237 Free PMC article.
References
-
- Adams H, Emerson T, Kirby M, Neville R, Peterson C, Shipman P, Chepushtanova S, Hanson E, Motta F, Ziegelmeier L, 2017. Persistence images: A stable vector representation of persistent homology. J. Mach .
-
- Akazawa K, Tamaki Y, Taguchi T, Tanji Y, Miyoshi Y, Kim SJ, Ueda S, Yanagisawa T, Sato Y, Tamura S, et al. , 2006. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy. The breast journal 12, 130–137. - PubMed
-
- Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DS, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, et al. , 2019. Population-based assessment of the association between magnetic resonance imaging background parenchymal enhancement and future primary breast cancer risk. Journal of Clinical Oncology 37, 954. - PMC - PubMed
-
- Badano A, Graff CG, Badal A, Sharma D, Zeng R, Samuelson FW, Glick SJ, Myers KJ, 2018. Evaluation of Digital Breast Tomosynthesis as Replacement of Full-Field Digital Mammography Using an In Silico Imaging Trial. JAMA Network Open 1, e185474–e185474. URL: https://doi.org/10.1001/jamanetworkopen.2018.5474, doi: 10.1001/jamanetworkopen.2018.5474. - DOI - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical